Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCRM.L Regulatory News (FCRM)

  • There is currently no data for FCRM

Relationship Agreement & Tender Offer Withdrawal

5 Jun 2020 07:01

RNS Number : 0432P
Harwood Capital LLP
05 June 2020
 

Not for release, publication or distribution, in whole or in part, DIRECTLY OR INDIRECTLY in, into or from any jurisdiction (including the united states) where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction. 

this announcement contains inside information FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) No. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

5 June 2020

Harwood Capital LLP

Withdrawal of Proposed Tender Offer

Relationship Agreement with Fulcrum and

Proposed Appointment of Harwood Representative to the Fulcrum Board

Further to today's announcement by Fulcrum, and discussions with its board of directors (the "Fulcrum Board"), on certain matters regarding the composition of the Fulcrum Board, Harwood Capital LLP ("Harwood") is pleased to confirm that it has withdrawn its proposed Tender Offer and has entered into a relationship agreement with Fulcrum (the "Relationship Agreement"), pursuant to which, inter alia, Harwood has the right to appoint a Non-Executive Director as its representative to the Fulcrum Board (the "Harwood Representative").

Accordingly, Harwood is pleased to announce that, subject to the completion of Fulcrum's customary standard due diligence procedures, Jeremy Brade will be appointed as the Harwood Representative to the Fulcrum Board.

Harwood and the Harwood Funds are currently interested in 24,515,000 Fulcrum Shares, representing approximately 11.04 per cent. of Fulcrum's existing issued share capital.

Harwood welcomes the proposed further changes to the Fulcrum Board under its transition plan, involving the intended appointment of two independent non-executive directors prior to the conclusion of Fulcrum's Annual General Meeting in 2021, one of whom will assume the role of chairman.

Harwood is pleased to note that Bayford Group, Fulcrum's largest shareholder, with a disclosed holding of 13.31 per cent. of Fulcrum's existing issued share capital, has entered into a separate relationship agreement with Fulcrum, pursuant to which, inter alia, Bayford Group has the right to appoint a Non-Executive Director as its representative to the Fulcrum Board (the "Bayford Representative"). Accordingly, Harwood welcomes, subject to the completion of Fulcrum's customary standard due diligence procedures, Jonathan Turner's appointment as the Bayford Representative.

Harwood is also pleased to note the proposed amendments to Fulcrum's Articles of Association, subject to shareholder approval, to incorporate additional protections typically available to UK public companies that are subject to the provisions of the City Code on Takeovers and Mergers, which are not currently available to Fulcrum or its shareholders as a company incorporated in the Cayman Islands.

Harwood's representative looks forward to working with the Fulcrum Board, and its executive management team, to create shareholder value going forwards, and would like to take this opportunity to thank all those Fulcrum Shareholders who made direct contact with Harwood to express an interest in receiving further information in respect of the proposed Tender Offer.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as those defined in Harwood's announcement of 8 April 2020.

Enquiries:

Harwood Capital LLP

Jeremy Brade, Partner

James Agnew, Partner

 

Tel: +44 (0)207 640 3200

Strand Hanson Limited

(Financial Adviser to Harwood Capital LLP)

Stuart Faulkner

Matthew Chandler

Jack Botros

 

Tel: +44 (0)207 409 3494

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFZGGVMDLGGZZ
Date   Source Headline
4th Oct 20237:00 amRNSCancellation - Fulcrum Utility Services Ltd
27th Sep 20235:45 pmRNSFulcrum Utility Services
26th Sep 20232:00 pmRNSResult of General Meeting
26th Sep 20232:00 pmRNSResult of AGM
21st Sep 202310:30 amRNSNotice of GM
21st Aug 20237:01 amRNSFinal Results
21st Aug 20237:00 amRNSProposed AIM Cancellation
1st Jun 20239:25 amRNSDomestic Asset Sale Update
23rd May 202312:25 pmRNSResults of GM
3rd May 20233:35 pmRNSNotice of GM
6th Apr 20237:00 amRNSTrading Update and Amendment to Loan Facility
16th Feb 20234:40 pmRNSSecond Price Monitoring Extn
16th Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20232:34 pmRNSResponse re. share price movement
14th Dec 20227:00 amRNSInterim Results
7th Dec 20224:40 pmRNSSecond Price Monitoring Extn
7th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
5th Dec 20229:05 amRNSSecond Price Monitoring Extn
5th Dec 20229:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSConvertible Loan Facility Agreement
1st Dec 202212:10 pmRNSDomestic Asset Sale Update
24th Oct 20227:00 amRNSTrading Update
27th Sep 20227:00 amRNSNotice of cyber security incident
16th Sep 20224:40 pmRNSSecond Price Monitoring Extn
16th Sep 20224:35 pmRNSPrice Monitoring Extension
16th Sep 20222:06 pmRNSSecond Price Monitoring Extn
16th Sep 20222:00 pmRNSPrice Monitoring Extension
16th Sep 202211:05 amRNSSecond Price Monitoring Extn
16th Sep 202211:00 amRNSPrice Monitoring Extension
14th Sep 20221:45 pmRNSResult of AGM
9th Sep 202211:05 amRNSSecond Price Monitoring Extn
9th Sep 202211:00 amRNSPrice Monitoring Extension
9th Sep 202210:00 amRNSHolding(s) in Company
8th Sep 20225:25 pmRNSDirector/PDMR Shareholding
25th Aug 20224:00 pmRNSNotice of AGM, Annual Report and Investor Meeting
1st Aug 20227:00 amRNSFinal Results
21st Jun 20224:35 pmRNSPrice Monitoring Extension
1st Jun 20227:00 amRNSDomestic Asset Sale Update
24th May 20222:45 pmRNSDirector/PDMR Shareholding
13th May 20222:05 pmRNSSecond Price Monitoring Extn
13th May 20222:00 pmRNSPrice Monitoring Extension
13th May 202211:05 amRNSSecond Price Monitoring Extn
13th May 202211:00 amRNSPrice Monitoring Extension
13th May 20229:05 amRNSSecond Price Monitoring Extn
13th May 20229:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.